Peripheral Neuropathy

The FDA granted an encorafenib-led combination accelerated approval for the treatment of certain patients with metastatic colorectal cancer.

The FDA has cleared an investigational new drug application for an epigenetic regulator to treat intractable pain due to idiopathic small fiber neuropathy, according to the manufacturer.

Patients with type 2 diabetes and more severe peripheral neuropathy appeared to be at greater risk for developing dry eye disease, according to a study published in Optometry and Vision Science.

ANAHEIM, Calif. — A woman who could not tolerate immunoglobulin replacement therapy benefitted from C1-INH replacement therapy, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.

Individuals with insufficient levels of vitamin D prior to treatment with paclitaxel are at higher risk for developing chemotherapy-induced peripheral neuropathy, study results showed.

Chemotherapy-induced peripheral neuropathy is a potentially debilitating, often persistent adverse event associated with taxane-based chemotherapy.

A 6-month aerobic exercise intervention significantly improved self-reported chemotherapy-induced peripheral neuropathy among women who underwent chemotherapy for ovarian cancer, according to study results published in JAMA Network Open.

Two-thirds of patients with breast cancer treated with taxane-based therapy experienced clinically meaningful chemotherapy-induced peripheral neuropathy symptoms during the first year of treatment, according to prospective study results.

The blood-based measure of neurofilament light chain was associated with the presence of neuronal injury in those with peripheral neuropathy, according to a systematic review and meta-analysis in JAMA Network Open.

Use of different antibody-drug conjugates resulted in a variety of significant and in some cases serious treatment‐associated adverse events, according to results of a systematic review and meta-analysis published in Cancer.